The deviation of the mechanical leg axis correlates with an increased hip alpha angle and could be a predictor of femoroacetabular impingement

Autor: Sonja Zirke, Christoph von Schulze Pellengahr, Lars Victor von Engelhardt, Matthias Lahner, Kiriakos Daniilidis, Gregor Vetter, Marco Hagen, Wolfram Teske, Nadine-Lucie Jahnke

Publikováno v: International Orthopaedics. 38:19-25

This study was designed to evaluate whether the mechanical axis deviation (MAD) of the leg correlates with an increased hip alpha angle as described by Nötzli, which is associated with femoroacetabular impingement (FAI).In a retrospective analysis,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc59604b5b94599d0bc3ca4154b2d4af
https://doi.org/10.1007/s00264-013-2085-0

Increased CNS uptake and enhanced antinociception of morphine-6-glucuronide in rats after inhibition of P-glycoprotein

Autor: Ellen Niederberger, Gregor Vetter, Gerd Geisslinger, Rodolfo Schmidt, Jörn Lötsch, Irmgard Tegeder, Helmut Schmidt

Publikováno v: Journal of Neurochemistry. 83:241-248

Morphine-6-glucuronide (M6G) is a substrate of P-glycoprotein (P-gp), which forms an outward transporter at the blood–brain barrier. Inhibition of P-gp may therefore be expected to cause increased CNS uptake of M6G. We directly assessed the spinal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::984393fdd64165c6a78fe209066e0613
https://doi.org/10.1046/j.1471-4159.2002.01177.x

Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas

Autor: T Junginger, C.-H. Köhne, E Mattes, E. Staib-Sebler, H J Gassel, H H Mueller, S. Heinrich, Gregor Vetter, M. Lorenz, H. Schramm, H D Saeger

Publikováno v: Annals of Oncology. 12:321-325

Summary Backgrounds: A multicenter phase II trial was initiated in order to evaluate the weekly, high-dose 24-hour infusion of 5-fluorouracil (5-FU) plus folinic acid (FA) in patients with unresectable colorectal cancer hepatic metastases. Paitents a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3671b8d6d159bee5539c41e48b121178
https://doi.org/10.1023/a:1011181700258

Contents Vol. 23, 2006

Autor: Gregor Vetter, C.D. Johnson, G. Srikanth, Koroush S. Haghighi, Dalibor Antolovic, Nikolay V. Emelyanov, Kazuhisa Yoshimoto, E.C.J. Consten, Marino Murazio, A. Kumar, L.S.F. Yo, Gennaro Clemente, R. Saxena, B. Pottakkat, Dirk J. Gouma, Dinesh Singhal, Katsuhiko Yanaga, Mikhail V. Kukosh, Hidejiro Kawahara, Abraham R. John, Ivo Giovannini, Shin Kon Kim, P.A. Yannopoulos, M. Gagner, Carlo Chiarla, Katsuya Hirai, Neerav Goyal, C. Fox, Dirk T. Ubbink, Yu Meng Tan, Maxim S. Petrov, Willem A. Bemelman, Kentaro Chochi, M. Emad Esmat, Christos Dervenis, Phillippe Taniere, Thomas M. van Gulik, G.R. Sagor, I.E. Katsoulis, J.I. Livingstone, Young Kyu Park, Bernard Launois, Young Jin Kim, Jörg Köninger, P. Basnyat, Arash Choudhry, G. Kouraklis, George Tzovaras, Jürgen Weitz, Arianeb Mehrabi, A. Arif, Gennaro Nuzzo, S. Singh, Jan Wind, S.S. Sikora, Khoon Hean Tay, Dong Yi Kim, Beat P. Müller-Stich, Salleh Ibrahim, H.M.E. Quarles van Ufford, Takashi Ichikura, Carsten N. Gutt, Jae Kyoon Joo, Felice Giuliante, V.K. Kapoor, Simon R. Bramhall, Hidekazu Sugasawa, Hideyuki Kashiwagi, Hidetaka Mochizuki, Ngian Chye Tan, A. Chaudhary, Seong Yeob Ryu, Markus W. Büchler, Steve M. M. de Castro, Susumu Kobayashi, H.G. Gooszen, J.F. Robotis, S. W. Polle, Daan W. Hommes

Publikováno v: Digestive Surgery. 23:395-397

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0da4bb9991558204c5e406e008d53b64
https://doi.org/10.1159/000099289

Celecoxib loses its anti‐inflammatory efficacy at high doses through activation of NF‐κB

Autor: Gregor Vetter, Gerd Geisslinger, Helmut Schmidt, Christian Euchenhofer, Ellen Niederberger, Irmgard Tegeder, Sabine Grösch, Achim Schmidtko, Lutz Bräutigam

Publikováno v: Europe PubMed Central

SPECIFIC AIMSCelecoxib is a cyclooxygenase-2 (COX-2) selective, nonsteroidal anti-inflammatory drug (NSAID) with low gastrointestinal toxicity. In clinical studies, 800 mg/day were somewhat less ef...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5edaffa99edd751a9e91f6ce34643a7b
https://doi.org/10.1096/fj.00-0716fje